| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |